ENLIVEX THERAPEUTICS LTD's ticker is ENLV and the CUSIP is M4130Y106. A total of 21 filers reported holding ENLIVEX THERAPEUTICS LTD in Q2 2023. The put-call ratio across all filers is 0.16 and the average weighting 0.0%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Susquehanna International Group Ltd. | 15,091 | $39,689 | 0.03% |
| Compagnie Lombard Odier SCmA | 65,000 | $171,146 | 0.01% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 13,000 | $34,190 | 0.00% |
| OSAIC HOLDINGS, INC. | 400 | $1,050 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 838 | $2,202 | 0.00% |
| WELLS FARGO & COMPANY/MN | 8,882 | $23,336 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 1,100 | $2,893 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 10,420 | $27,404 | 0.00% |
| GOLDMAN SACHS GROUP INC | 11,297 | $29,681 | 0.00% |
| MORGAN STANLEY | 43,851 | $115,209 | 0.00% |
| Citadel Advisors | 5,800 | $15,254 | 0.00% |
| Citadel Advisors | 10,300 | $27,089 | 0.00% |
| Citadel Advisors | 38,615 | $101,557 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 59,700 | $157,011 | 0.00% |
| SIMPLEX TRADING, LLC | 12,675 | $33 | 0.00% |
| Steward Partners Investment Advisory, LLC | 3,000 | $7,882 | 0.00% |
| Red Tortoise LLC | 150 | $394 | 0.00% |
| JPMORGAN CHASE & CO | 2,379 | $6,257 | 0.00% |
| Renaissance Technologies | 56,689 | $149 | 0.00% |
External links
This page lists ENLIVEX THERAPEUTICS LTD's shareholders in Q2 2023. To view ENLIVEX THERAPEUTICS LTD's shareholder history, click here.